Evangelia Pliakou

6PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 27, 2026
Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.

Hector Katifelis, Styliani-Evangelia Zerva, Aristotelis Bamias

|Jul 29, 2025
Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives.

Dimitrios Papageorgiou, Galateia Liouta, Evangelia Pliakou

|Jan 08, 2025
HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions.

Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou

|Jan 08, 2023
Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer.

Evangelia Pliakou, Dimitra Ioanna Lampropoulou, Nikolas Dovrolis

|May 09, 2022
Synchronous Gastric Adenocarcinoma and Diffuse Large B-Cell Lymphoma in the Pelvis: A Rare Case Presentation.

Evangelia Pliakou, Dimitra-Ioanna Lampropoulou, Nikolaos Soupos

|Feb 15, 2022
The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.

Dimitra Ioanna Lampropoulou, Evangelia Pliakou, Gerasimos Aravantinos

Pageof 1